{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Randomised Controlled Trial on Perioperative Warming Strategies"
      },
      "Trial_Design": {
        "score": 2,
        "evidence": "The sample size was calculated to ensure adequate power."
      },
      "Participants": {
        "score": 2,
        "evidence": "Participants were adult surgical patients meeting specific eligibility criteria."
      },
      "Intervention": {
        "score": 2,
        "evidence": "Participants were randomly assigned to either the intervention group receiving forced air warming (FAW) or the control group receiving passive warming methods."
      },
      "Objective": {
        "score": 1,
        "evidence": "This study evaluates the effectiveness of various warming strategies."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was the maintenance of core body temperature, measured intraoperatively."
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation was computer-generated, and allocation was concealed using sealed envelopes."
      },
      "Blinding": {
        "score": 1,
        "evidence": "Blinding was applied to outcome assessors."
      },
      "Number_Randomised": {
        "score": 2,
        "evidence": "A total of 200 participants were randomised: 100 to the FAW group and 100 to the control group, between January 2020 and June 2021."
      },
      "Number_Analysed": {
        "score": 2,
        "evidence": "Analysis was conducted on 98 participants in the FAW group and 97 in the control group using an intention-to-treat approach."
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "The FAW group showed a significant improvement in core temperature maintenance (mean difference = 0.5\u00b0C, 95% CI 0.3 to 0.7; p < 0.01)."
      },
      "Harms": {
        "score": 1,
        "evidence": "Adverse events were reported in 3% of the FAW group and 1% of the control group, with mild severity."
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "Trial registration: NCT12345678."
      },
      "Funding": {
        "score": 1,
        "evidence": "Funding: Supported by the National Institute of Health."
      }
    },
    "total_score": 23,
    "max_score": 25
  },
  "model": "gpt-4o"
}